Recognized standard
21362 First edition 2026-02
FDA recognition 18-25 · ISO · Nanotechnology
Key facts
| Recognition number | 18-25 |
|---|---|
| Designation | 21362 First edition 2026-02 |
| Title | Nanotechnologies -- Analysis of nano-objects using asymmetrical flow and centrifugal field-flow fractionation |
| Standards developer | International Organization for Standardization |
| Specialty area | Nanotechnology |
| Date of entry | May 25, 2026 |
| Scope (excerpt) | This document describes the general principles of field-flow fractionation and specifies parameters, conditions and minimal reporting requirements, as part of an integrated measurement system, required to develop and validate methods for the application of asymmetrical flow and centrifugal… |
At a glance
- None Product codes
- 1–9 FDA guidance documents
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA-recognized consensus standards
The FDA recognizes voluntary consensus standards that manufacturers can cite in premarket submissions to show conformity with specific requirements.
Source: U.S. Food and Drug Administration (FDA), Recognized Consensus Standards database · Source date: